KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Asset Utilization Ratio (2016 - 2026)

AbbVie has reported Asset Utilization Ratio over the past 13 years, most recently at 0.46 for Q4 2025.

  • Quarterly Asset Utilization Ratio rose 12.91% to 0.46 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.46 through Dec 2025, up 12.91% year-over-year, with the annual reading at 0.45 for FY2025, 8.87% up from the prior year.
  • Asset Utilization Ratio was 0.46 for Q4 2025 at AbbVie, up from 0.44 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.46 in Q4 2025 and troughed at 0.33 in Q1 2021.
  • The 5-year median for Asset Utilization Ratio is 0.4 (2023), against an average of 0.4.
  • The largest YoY upside for Asset Utilization Ratio was 36.78% in 2021 against a maximum downside of 11.73% in 2021.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.38 in 2021, then increased by 8.93% to 0.41 in 2022, then decreased by 3.26% to 0.4 in 2023, then grew by 0.86% to 0.4 in 2024, then increased by 12.91% to 0.46 in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Asset Utilization Ratio are 0.46 (Q4 2025), 0.44 (Q3 2025), and 0.43 (Q2 2025).